Factual and Procedural Background
The present claim concerns a complex financial transaction initiated by Company A ("RBS") involving the monetisation of an economic interest in a power plant subsidiary ("ETOL") of Enron Corp ("Enron"). On 22nd September 2000, the Group Credit Committee of Company A described the transaction as "21st Century Alchemy" due to its innovative accounting treatment under US GAAP, specifically FAS 125. Company A formed a Special Purpose Entity ("RBSFT") capitalised with approximately 3.5% equity and 96.5% debt, which purchased preference shares issued by an Enron subsidiary. The debt was guaranteed by Enron through a Total Return Swap ("TRS").
Company A syndicated the loan to various banks, including Company B ("RZB"), which lent £10,000,000. Company B alleges it was induced to participate by misrepresentations made by Company A and seeks to recover its losses following Enron's collapse and bankruptcy in December 2001.
The transaction was structured to allow Enron to recognise a profit in its accounts by selling its economic interest while not reflecting the associated borrowing on its balance sheet. The equity portion was supported only by oral assurances from Enron to Company A, promising repayment plus a fixed return, but without formal contractual backing. Company B was not informed of these oral assurances.
Company B participated in the syndication after receiving an Information Memorandum and Confidentiality Agreement prepared and coordinated by Company A and Enron. The syndication process involved several internal credit committee approvals within Company B, culminating in its participation on 28th February 2001.
The claim alleges that Company A misrepresented material facts about the nature of the equity risk and the transaction’s accounting treatment, inducing Company B to lend money it otherwise would not have lent.
Legal Issues Presented
- Whether Company A made representations to Company B that were false or misleading concerning the nature of its equity investment in RBSFT and the unwinding of the ETOL transaction.
- Whether Company B understood and relied upon such representations in deciding to participate in the syndicated loan.
- Whether Company A intended to induce Company B to enter into the Syndication Agreement by making such representations.
- Whether certain contractual provisions in the Information Memorandum, Confidentiality Agreement, and Facility Agreement preclude or limit Company B's claims (contractual estoppel and exclusion clauses).
- Whether Enron's oral assurances to Company A were legally binding and their effect on the characterization of Company A's equity investment as "at risk" under US GAAP.
- Whether Company A acted fraudulently or dishonestly in relation to the representations and the transaction.
- The appropriate measure of damages if misrepresentation is established.
Arguments of the Parties
Claimant's (Company B) Arguments
- Company A represented that its equity investment was "at risk" without any support or assurance beyond what was disclosed in the transactional materials.
- Company A represented that the transaction would be unwound as stated, including the price to be paid for the preference shares.
- Company A represented that the transaction lawfully monetised Enron's dividend stream while retaining voting rights and complied with accounting principles.
- Company A represented that there was nothing improper or unlawful about the transaction or its accounting treatment.
- Company A withheld material information about oral assurances from Enron that Company A would be made whole on its equity investment, inducing Company B to participate without full disclosure.
- Company A acted dishonestly by concealing the assurances and the true nature of the transaction's accounting treatment.
- Company B relied on these representations and suffered loss following Enron's collapse.
Defendant's (Company A) Arguments
- Company A contends that the representations were not made or were not understood by Company B as alleged.
- The Information Memorandum and Confidentiality Agreement expressly disclaimed any representation or warranty as to the accuracy or completeness of the information provided.
- Company B, as a sophisticated participant, was aware of and accepted the limitations of the Information Memorandum.
- Enron's oral assurances were not legally binding and could not affect the characterization of the equity as "at risk" for accounting purposes.
- The equity investment was indeed "at risk" because the assurances were non-contractual and unenforceable.
- Company A did not act dishonestly or fraudulently; multiple witnesses confirmed that the understanding was that the assurances were non-binding and that the transaction complied with accounting rules.
- Company B was not induced by any misrepresentation to enter the Syndication Agreement; any alleged misrepresentation was not a real and substantial cause of Company B's decision.
- Contractual provisions in the Confidentiality Agreement and Facility Agreement operate as an estoppel and exclusion of liability for any alleged misrepresentations.
- Even if misrepresentation were found, Company A reasonably believed the representations to be true.
Table of Precedents Cited
| Precedent |
Rule or Principle Cited For |
Application by the Court |
| MCI WorldCom International Inc v Primus Telecommunications Inc [2004] EWCA Civ 957 |
Objective test for determining whether a statement constitutes a representation, considering characteristics of the representee. |
Applied to assess whether Company A made representations to Company B. |
| IFE Fund SA v Goldman Sachs International [2007] 1 Lloyd's Rep 264 |
Interpretation of express and implied representations in financial information memoranda. |
Used to analyze the nature of the representations in the Information Memorandum and disclaimers. |
| Geest plc v Fyffes plc [1999] 1 All ER (Comm) 672 |
Test for implied misrepresentation and suppressio veri, suggestio falsi. |
Considered in evaluating whether non-disclosure implied a false representation. |
| Royscot Trust Ltd v Rogerson [1991] 2 QB 297 |
Measure of damages under Misrepresentation Act 1967 s.2(1) is the same as for deceit. |
Determined the measure of damages recoverable by Company B. |
| Dadourian v Simms [2009] EWCA Civ 169 |
Misrepresentation must play a real and substantial part in inducing contract. |
Applied to assess inducement by alleged misrepresentations. |
| Assicurazioni Generali SpA v Arab Insurance Group [2003] 1 All ER (Comm) 140 |
Clarifies the requirement of "but for" causation in inducement for misrepresentation claims. |
Used to analyze causation and inducement in the claim. |
| Pan Atlantic Insurance Co Ltd v Pine Top Insurance Co Ltd [1995] 1 AC 501 |
Materiality and inducement tests in insurance contracts applied analogously to misrepresentation claims. |
Considered in the context of inducement and causation. |
| Barton v Armstrong [1976] AC 104 |
In cases of duress or fraud, misrepresentation need only be one cause of entering contract. |
Distinguished from non-fraudulent misrepresentation in causation analysis. |
| Colchester Borough Council v Smith [1991] Ch 448 |
Contractual estoppel arising from agreed basis of fact between parties. |
Applied to assess effect of contractual provisions disclaiming representations. |
| William Sindall Plc v Cambridgeshire County Council [1994] 1 WLR 1016 |
Distinction between clauses excluding liability for misrepresentation and those defining basis of contract. |
Considered in construing disclaimers in the Information Memorandum and Confidentiality Agreement. |
| Lowe v Lombank [1960] 1 WLR 196 |
Requirements for estoppel by representation and distinction from contractual promise. |
Discussed in relation to contractual estoppel and disclaimers. |
| Peekay Intermark v ANZ Banking Group [2006] EWCA Civ 386 |
Contractual estoppel and non-reliance clauses enforceable in commercial contracts. |
Applied to uphold disclaimers in contractual documentation. |
| Springwell Navigation Corp v JP Morgan Chase Bank [2008] EWCA Civ 1186 |
Contractual estoppel precluding claims where parties agreed no reliance on representations. |
Applied to bar claims inconsistent with contractual disclaimers. |
| IFE Fund SA v Goldman Sachs International [2007] EWCA Civ 811 |
Distinguishing between exclusion of liability and whether representation was made. |
Applied to interpret disclaimers in financial information memoranda. |
| Derry v Peek (1889) 14 App Cas 337 |
Requirement of fraudulent knowledge in deceit claims. |
Applied to assess allegations of fraud against Company A. |
| AIC Ltd v ITS Trading Services (UK) Ltd [2007] 1 All ER (Comm) 667 |
Clarification on the element of dishonesty in deceit claims. |
Used to evaluate the evidence on fraud allegations. |
| Smith New Court Securities Ltd v Scrimgeour Vickers [1997] AC 254 |
Measure of damages for deceit claims. |
Applied to determine damages recoverable by Company B if successful. |
| Watford Electronics Ltd v Sanderson CFL Ltd [2001] 1 All ER (Comm) 696 |
Commercial fairness and reasonableness of contractual disclaimers. |
Considered in assessing reasonableness of disclaimers under Misrepresentation Act 1967 s.3. |
| Government of Zanzibar v British Aerospace [2000] 1 WLR 2333 |
Contractual non-reliance clauses and their interaction with Misrepresentation Act 1967 s.3. |
Applied in construing contractual disclaimers. |
| Thomas Witter Ltd v TBP Industries Ltd [1992] 2 All ER 573 |
Effect of non-reliance clauses on misrepresentation claims. |
Considered in context of contractual disclaimers. |
| William Sindall Plc v Cambridgeshire County Council [1994] 1 WLR 1016 |
Whether statements qualify as representations for purposes of exclusion clauses. |
Applied to assess disclaimers in this case. |
| Coastal (Bermuda) Petroleum Ltd v VTT Vulcan Petroleum SA (No 2) [1994] 2 Lloyd's Rep 629 |
Legal effect of assurances given dehors the courts. |
Referenced regarding non-contractual assurances. |
Court's Reasoning and Analysis
The court conducted a detailed examination of the transaction structure, the nature of the representations alleged, the context in which information was provided to Company B, and the contractual documentation governing the transaction. The court emphasized the sophistication of the parties and the standard market practice of disclaiming representations in Information Memoranda and Confidentiality Agreements.
Regarding the alleged representations, the court found that the first two key representations—that Company A's equity in RBSFT was "at risk" without support beyond transactional materials, and that the unwind of the ETOL transaction would occur as described—were not expressly or impliedly made to Company B in the manner alleged. The court noted that the Information Memorandum primarily addressed the debt portion of the transaction and that details about the equity, including any support or assurances, were minimal and confidential between Company A and Enron.
The court found that Company B did not understand or rely on the alleged representations as required for a misrepresentation claim. The oral assurances from Enron to Company A were held not to be legally binding, as their binding nature would have undermined the accounting treatment sought by Enron. The court accepted that these assurances were strong commercial promises but not enforceable obligations. The equity was thus properly characterised as "at risk" under US GAAP.
The court analyzed the contractual provisions in the Confidentiality Agreement, Information Memorandum, and Facility Agreement, concluding that these provisions constituted a contractual estoppel preventing Company B from asserting that representations were made beyond those expressly stated. These provisions also operated as disclaimers excluding or limiting liability for misrepresentations, which the court found to be reasonable and appropriate in the context of sophisticated commercial parties.
On the issue of inducement, the court held that even if the alleged misrepresentations had been made, Company B had not shown that they were a real and substantial cause of its decision to participate. Contemporaneous documents demonstrated that Company B viewed the risk as primarily Enron corporate risk and was comfortable with the syndication on that basis.
The court rejected allegations of fraud or dishonesty by Company A or its representatives, finding no evidence that Company A knowingly or recklessly misrepresented facts or concealed material information with intent to deceive Company B.
On the accounting issues, the court undertook an extensive review of US GAAP, FAS 125, and related pronouncements, concluding that the equity investment was properly considered "at risk" and that the transaction's accounting treatment was within the range of reasonable professional judgment. The court preferred the expert evidence supporting this conclusion.
Finally, the court addressed the measure of damages, noting the binding authority that damages under the Misrepresentation Act 1967 s.2(1) are assessed on the same basis as deceit, allowing recovery of all losses flowing from the misrepresentation.
Holding and Implications
DISMISSED
The court dismissed Company B's claim for misrepresentation and deceit against Company A. It held that Company B had not established that Company A made the alleged representations or that Company B relied on them to its detriment. The oral assurances from Enron to Company A were not legally binding and did not negate the "at risk" nature of the equity investment. Contractual provisions disclaiming representations and limiting liability were effective and reasonable. There was no evidence of fraud or dishonesty by Company A.
The decision results in Company B being unable to recover losses from Company A in respect of its participation in the syndicated loan facility. The ruling does not establish new legal precedent but reaffirms established principles regarding the interpretation of disclaimers in complex financial transactions, the nature of "at risk" equity under US GAAP, and the requirements for misrepresentation claims in sophisticated commercial contexts.